DoxorubicinAdjuvants, ImmunologicChemotherapy, AdjuvantAntibiotics, AntineoplasticFreund's AdjuvantAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, AdjuvantCyclophosphamideAdjuvants, PharmaceuticBreast NeoplasmsVincristineAntineoplastic AgentsRazoxaneCombined Modality TherapyTreatment OutcomeLiposomesDrug Resistance, NeoplasmDisease-Free SurvivalDrug CarriersFluorouracilCisplatinP-GlycoproteinDrug Administration SchedulePaclitaxelSurvival AnalysisCell Line, TumorPrednisoneVinblastineNeoplasm StagingDrug Resistance, MultipleEtoposidePolyethylene GlycolsDose-Response Relationship, DrugMethotrexateAluminum HydroxideNeoplasm Recurrence, LocalAnthracyclinesTamoxifenSurvival RateSarcomaMice, Inbred BALB CDaunorubicinDrug SynergismPrognosisEpirubicinIfosfamideApoptosisTime FactorsTumor Cells, CulturedImmunizationLeukemia P388Drug Delivery SystemsBleomycinCardiotoxinsHydroxyethylrutosideAntineoplastic Agents, HormonalTaxoidsNeoadjuvant TherapyCell SurvivalDrug ResistanceDrug Screening Assays, AntitumorMitoxantroneInfusions, IntravenousOsteosarcomaLymphatic MetastasisVaccinesFollow-Up StudiesAdministration, IntranasalLung NeoplasmsAdenocarcinomaAntineoplastic Agents, PhytogenicHeart DiseasesBone NeoplasmsNeoplasm MetastasisColonic NeoplasmsSoft Tissue NeoplasmsDacarbazineCardiomyopathiesHeartMice, NudeVerapamilArthritis, ExperimentalMice, Inbred C57BLProcarbazineDNA Topoisomerases, Type IIAntibody FormationRetrospective StudiesOvarian NeoplasmsClinical Trials as TopicImmunoglobulin GVaccines, SubunitNeoplasmsAntibodies, MonoclonalSqualeneNeoplasm TransplantationNanocapsulesReceptor, erbB-2ProdrugsXenograft Model Antitumor AssaysLeukopenia